Join to access to all OVN content. Join for Free
MSL Training: The Path of Continued Learning and Development
MSL training medical science liaison skills soft skills in healthcare operational training for MSLs career transition for MSLs

MSL Training: The Path of Continued Learning and Development


Share This Article


Summary

In this episode, Michael Parisi and Marissa Polly from GuideMark Health join to explore the evolving training needs of Medical Science Liaisons (MSLs). They discuss the essential scientific and clinical skills required, alongside strategies for reengaging field medical teams post-COVID. The conversation highlights the importance of soft skills and empathy in MSL success, and offers insights into enhancing operational training and territory management. Michael and Marissa also address the challenges new MSLs face during career transitions, inviting listener input. The episode concludes with closing remarks and a note of appreciation, with GuideMark Health as the sponsor.

Check out my latest podcast with Michael Parisi and Marissa Poli of Guidemark Health as we cover MSL Training: The Path of Continued Learning and Development.

We discuss:

 Core Competency-Scientific and Clinical Training
 Soft Skills and Empathy Training
 Operational Skills in a Virtual World
 Career On Ramp Training

Click for Source
MSL training, medical science liaison skills, soft skills in healthcare, operational training for MSLs, career transition for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Podcast
Prepare to LAUNCH: How to Build an MSL Team From Scratch
Partner Avatar MSL Talk: Tom Caravela, John Caskey

Prepare to LAUNCH: How to Build an MSL Team From Scratch

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN